KOVAI vs RUBICON: Stock Comparison
Kovai Medical Center & Hospital Ltd vs Rubicon Research Limited
Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings
Rubicon Research Limited is the larger company by market capitalisation. Kovai Medical Center & Hospital Ltd shows a lower P/E, a higher dividend yield and a higher net margin, while Rubicon Research Limited shows a higher ROE, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Side-by-side comparison of Kovai Medical Center & Hospital Ltd and Rubicon Research Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | KOVAI | RUBICON |
|---|---|---|
| Sector | — | Healthcare |
| Industry | — | Pharmaceuticals |
Price
| Metric | KOVAI | RUBICON |
|---|---|---|
| Live Price | ₹5,845 | ₹1,520.2 |
| Day Change | 1.64% | -0.34% |
| Volume | 2,149 | 1.84 L |
| 52-Week High | ₹6,340 | ₹1,547.3 |
| 52-Week Low | ₹5,275.5 | ₹570.75 |
| Distance from 52W High | -7.81% | -1.75% |
Valuation
| Metric | KOVAI | RUBICON |
|---|---|---|
| Market Cap | ₹6,386 Cr | ₹25,045 Cr |
| P/E Ratio | 26.2x | 101.81x |
| P/B Ratio | 4.86x | 19.5x |
| EPS | ₹53 | ₹15.48 |
| Book Value | ₹264 | ₹78.22 |
| Dividend Yield | 0.17% | 0% |
Growth
| Metric | KOVAI | RUBICON |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | 43.5% |
| EPS Growth (TTM YoY) | 0% | 96.6% |
| Qtr Sales Growth | — | 43.5% |
| Qtr Profit Growth | — | 112% |
Profitability & Leverage
| Metric | KOVAI | RUBICON |
|---|---|---|
| ROE | 22.2% | 27% |
| ROCE | 24.1% | 28.4% |
| Net Margin | 15.42% | 13.48% |
| Operating Margin | 21.8% | 22.8% |
| Debt to Equity | 0.7x | 0.24x |
Shareholding
As of Mar 2026 • change vs previous quarter| Metric | KOVAI | RUBICON |
|---|---|---|
| Promoter Holding | 55.81% | 23.97%▼ 0.05 pp |
| FII Holding | 1.2%▼ 0.11 pp | 7.54%▼ 0.45 pp |
| DII Holding | 4.48%▼ 0.25 pp | 10.02%▲ 0.57 pp |
| Public Holding | 37.8%▲ 0.36 pp | 22.58%▲ 0.01 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Kovai Medical Center & Hospital Ltd and Rubicon Research Limited.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.